跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tricentisaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tricentisaph
Approved
STANDARD
Tricentisaph
Azine Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cd7394b0232b4370
Company
Azine Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
cd7394b0232b4370
Drug Approval Philippines Name
Tricentisaph
Product Name
Tricentisaph
Registration Number
DRP-13796
Brand Name
Tricentisaph
Generic Name
Salbutamol (as sulfate) + Bromhexine Hydrochloride + Guaifenesin
Dosage Form
Syrup
Dosage Strength
2 mg/ 4 mg/ 100 mg per 5 mL
Manufacturer
Azine Healthcare Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
24 April 2023
Expiry Date
24 April 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cd7394b0232b4370
Type
Standard
Back to Philippines FDA Approvals